|
|
 |
|
Viewing report
|
|
|
|
Analgesics in United Arab Emirates
Euromonitor International, April 2010, Pages: 27
Adult analgesics continued to be dominated by acetaminophen, which held a 44% value share in 2009, followed by Diclofenac. Acetaminophen also benefited from a movement away from aspirin, as studies suggested new risks associated with aspirin particularly for children; while key brands such as Panadol and Panadol Extra remained as bestsellers given their proven reputation, their potential to be used for a variety of common ailments and consumer familiarity with these products.
The Analgesics Products in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
.
Customers who bought this item also bought
Cough, Cold and Allergy (Hay Fever) Remedies in United Arab Emirates
Vitamins and Dietary Supplements in United Arab Emirates
Digestive Remedies in United Arab Emirates
Slimming Products in United Arab Emirates
Calming and Sleeping in United Arab Emirates
Wound Treatments in United Arab Emirates
OTC Healthcare - United Arab Emirates
Vitamins and Dietary Supplements in Bosnia-Herzegovina
Analgesics in USA
Analgesics in Singapore
|
|
|
|
